All 50 states and the District of Columbia have implemented newborn screening policies for critical congenital heart disease.
Maternal use of ondansetron during the first trimester of pregnancy was not found to be associated with cardiac or congenital malformation in offspring but may be linked to oral cleft development.
Projected increases in maternal heat exposure may result in increased congenital heart defect burden.
Although congenital heart defects are more frequent in offspring of mothers with overweight or obesity, the relationship between maternal overweight and obesity and risk for complex and specific heart defects is not well defined.
The pea-sized device is a self-expanding wire mesh that is inserted through an incision in the leg and guided through vessels to the heart, where it is placed to seal the opening.
Overall long-term transplant-free survival in repaired Tetralogy of Fallot is favorable.
HealthDay News — First-trimester ondansetron use is associated with a small increased risk for oral cleft but no increased risk for congenital malformations or cardiac malformations, according to a study published in the Dec. 18 issue of the Journal of the American Medical Association. Krista F. Huybrechts, Ph.D., from Brigham and Women’s Hospital in Boston,…
Investigators examined neuropsychological outcomes of children who survived pediatric cardiac arrest.
For live-born infants with hypoplastic left heart syndrome and d-transposition of the great arteries, Hispanic ethnicity is associated with poor outcome.
Children with past and current heart conditions have more special health care needs compared with children without heart conditions.